Preclinical News and Research

RSS
Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2 ADC

Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2 ADC

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

ANP reports positive results from chronic toxicity study of ATL1102 in multiple sclerosis

ANP reports positive results from chronic toxicity study of ATL1102 in multiple sclerosis

Evotec signs research collaboration and licensing deal with Debiopharm Group

Evotec signs research collaboration and licensing deal with Debiopharm Group

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Cedars-Sinai earns grant to conduct clinical trial of gene therapy product for patients with Lou Gehrig's disease

Cedars-Sinai earns grant to conduct clinical trial of gene therapy product for patients with Lou Gehrig's disease

FORMA Therapeutics signs second strategic collaboration and option agreement with Celgene

FORMA Therapeutics signs second strategic collaboration and option agreement with Celgene

EMD Serono collaborates with Pfizer and Broad Institute

EMD Serono collaborates with Pfizer and Broad Institute

New device simulates gastro-intestinal tract

New device simulates gastro-intestinal tract

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

NeuroVive presents clinical data of NVP018 for treatment of chronic hepatitis B infections at EASL

Senhwa Biosciences to present CX-5461 study results at AACR meeting

Senhwa Biosciences to present CX-5461 study results at AACR meeting

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

SAGE Therapeutics doses first patient in SAGE-547 Phase 1/2 trial for treatment of SRSE

Mephedrone drug causes acute withdrawal symptoms, shows study

Mephedrone drug causes acute withdrawal symptoms, shows study

Egalet provides business update, reports full year 2013 financial results

Egalet provides business update, reports full year 2013 financial results

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Adaptimmune awarded £2.1 million grant to expedite development of engineered T cell therapy

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

Inovio Pharmaceuticals receives three industry awards at World Vaccine Congress

HIV and Hepatitis C vaccines now closer to reality

HIV and Hepatitis C vaccines now closer to reality

Study explores dangers of switching from MDMA to mephedrone

Study explores dangers of switching from MDMA to mephedrone

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

BIND Therapeutics reports revenue of $2.1 million for fourth quarter 2013

Rexahn provides updates on clinical development programs, reports full-year 2013 financial results

Rexahn provides updates on clinical development programs, reports full-year 2013 financial results

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.